Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011. ,
Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-86, 2014. ,
Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status, J Thorac Oncol, vol.9, pp.1345-53, 2014. ,
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle, Ann Oncol, vol.25, pp.1729-1764, 2014. ,
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA, Nat Commun, vol.6, p.8258, 2015. ,
Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013. ,
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer, Nat Commun, vol.6, pp.1-6, 2015. ,
Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc Natl Acad Sci U S A, vol.102, pp.16368-73, 2005. ,
Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis, Cancer Epidemiol Biomarkers Prev, vol.24, pp.206-218, 2015. ,
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat Med, vol.20, pp.430-435, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168071
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012. ,
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin Chem, vol.59, pp.1722-1753, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299581
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci Transl Med, vol.4, pp.136-68, 2012. ,
Detection and quantification of rare mutations with massively parallel sequencing, Proc Natl Acad Sci U S A, vol.108, pp.9530-9535, 2011. ,
Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin Chem, vol.59, pp.815-838, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299583
Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299585
Validation and utilisation of highcoverage next-generation sequencing to deliver the pharmacological audit trail, Br J Cancer, vol.111, pp.828-864, 2014. ,
Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration, Clin Cancer Res, vol.21, pp.4586-96, 2015. ,
Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol.11, pp.2156-66, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02148770
Sequencing depth and coverage: key considerations in genomic analyses, Nat Rev Genet, vol.15, pp.121-153, 2014. ,
Performance comparison of benchtop high-throughput sequencing platforms, Nat Biotechnol, vol.30, pp.434-443, 2012. ,
Characterizing and measuring bias in sequence data, Genome Biol, vol.14, p.51, 2013. ,
Comparison of somatic mutation calling methods in amplicon and whole exome sequence data, BMC Genomics, vol.15, p.244, 2014. ,
,
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage, Nat Med, vol.20, pp.548-54, 2014. ,
Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients, Clin Cancer Res, vol.22, pp.915-937, 2016. ,
High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing, Proc Natl Acad Sci U S A, vol.110, pp.19872-19879, 2013. ,
Detection of ultra-rare mutations by nextgeneration sequencing, Proc Natl Acad Sci U S A, vol.109, pp.14508-14521, 2012. ,
Detecting ultralow-frequency mutations by Duplex Sequencing, Nat Protoc, vol.9, pp.2586-606, 2014. ,
Integrated digital error suppression for improved detection of circulating tumor DNA, Nat Biotechnol, vol.34, pp.547-55, 2016. ,
Accessing genetic information with liquid biopsies, Trends Genet, vol.31, pp.564-75, 2015. ,
, Comprehensive R Archive Network (CRAN). Plasma Mutation Detector Package, 2016.
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, vol.20, pp.1297-303, 2010. ,
, Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import, 2016.
An adjusted boxplot for skewed distributions, Comput Stat Data Analy, vol.52, pp.5186-201, 2008. ,
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium, BMC Cancer, vol.15, p.26, 2015. ,
An integrated semiconductor device enabling non-optical genome sequencing, Nature, vol.475, pp.348-52, 2012. ,
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing, Nat Med, vol.14, pp.579-84, 2008. ,
COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing, Clin Chem, vol.58, pp.580-589, 2012. ,
Reliable detection of subclonal singlenucleotide variants in tumour cell populations, Nat Commun, vol.3, p.811, 2012. ,
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity, Nat Biotechnol, vol.34, pp.155-63, 2016. ,
Subclonal variant calling with multiple samples and prior knowledge, Bioinformatics, vol.30, pp.1198-204, 2014. ,
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers, Clin Cancer Res, vol.19, pp.2240-2247, 2013. ,
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02), Oncotarget, vol.7, pp.6984-93, 2016. ,